Covaxin demonstrates protection against new Covid-19 variants

Covaxin demonstrates protection against new Covid-19 variants
SECTIONS
Last Updated: May 16, 2021, 01:25 PM IST
Share
Synopsis
A study published by Clinical Infectious Diseases found that vaccination with Covaxin produced neutralising titres against all key emerging variants tested including B1617 and B117, first identified in India and the UK, respectively.
PTI
Bharat Biotech's Covaxin retained neutralising activity against emerging variants of coronavirus, as per a new study.
Peer-review publication, Clinical Infectious Diseases, has noted that Covaxin demonstrates protection against the new Covid-19 variants.
Bharat Biotech's Covaxin retained neutralising activity against emerging variants of coronavirus, as per a new study.
A study published by Clinical Infectious Diseases found that vaccination with Covaxin produced neutralising titres against all key emerging variants tested including B1617 and B117, first identified in India and the UK, respectively.

Related Keywords

India ,United Kingdom , ,National Institute Of Virology ,Indian Council Of Medical Research ,Clinical Infectious Diseases ,National Institute ,Indian Council ,Bharat Biotechs Covaxin ,Covaxin ,Covid Indian Variant ,இந்தியா ,ஒன்றுபட்டது கிஂக்டம் ,தேசிய நிறுவனம் ஆஃப் வைராலஜி ,இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி ,மருத்துவ தொற்று நோய்கள் ,தேசிய நிறுவனம் ,இந்தியன் சபை ,